Many individuals recovering from ischemic stroke report persistent emotional challenges—even after their neurological deficits have stabilized. Clinicians increasingly recognize that post-stroke mood disturbances are not merely psychological reactions to disability, but reflect complex, interrelated pathophysiological mechanisms involving cerebral perfusion, neuroendocrine regulation, and systemic metabolic function.
First, impaired cerebral blood flow directly affects limbic and prefrontal regions critical for emotional regulation. These areas—particularly the anterior cingulate cortex, amygdala, and dorsolateral prefrontal cortex—are highly vulnerable to hypoxia and microvascular insufficiency. Even subtle reductions in regional perfusion can disrupt neurotransmitter synthesis (e.g., serotonin and dopamine), leading to irritability, anhedonia, and emotional lability—symptoms often misattributed solely to “adjustment difficulties.”
Second, motor or sensory deficits frequently trigger a cascade of psychosocial stressors, including loss of autonomy, occupational disruption, and altered self-perception. This functional decline activates the hypothalamic-pituitary-adrenal (HPA) axis and sympathetic nervous system, sustaining elevated cortisol and catecholamine levels—factors known to impair hippocampal neuroplasticity and exacerbate depressive symptomatology.
Third, emerging evidence highlights the role of hepatic and gastrointestinal dysfunction in post-stroke neuropsychiatric sequelae. Chronic stress and autonomic dysregulation post-stroke contribute to hepatic congestion and reduced bile acid metabolism, impairing the clearance of neuroactive metabolites such as quinolinic acid—a potent NMDA receptor agonist linked to neuronal excitotoxicity and mood dysregulation. Concurrently, disrupted circadian rhythms—especially fragmented or insufficient nocturnal sleep—impair hepatic detoxification pathways active during the late-night hours (1–3 a.m.), further compromising neurochemical homeostasis.
Fourth, post-stroke alterations in gut microbiota composition and intestinal barrier integrity may promote low-grade systemic inflammation and impair tryptophan metabolism—the rate-limiting precursor for serotonin biosynthesis. When combined with diminished splanchnic perfusion and pancreatic enzyme insufficiency, this contributes to malabsorption of key micronutrients—including B vitamins, magnesium, and omega-3 fatty acids—that serve as essential cofactors in monoamine synthesis and neuronal membrane stability.
Evidence-informed management therefore requires an integrated approach: structured, task-specific physical rehabilitation not only improves motor outcomes but also enhances cerebral perfusion and stimulates brain-derived neurotrophic factor (BDNF) expression; dietary interventions emphasizing anti-inflammatory, high-fiber, and tryptophan-rich foods (e.g., turkey, lentils, bananas, and walnuts) support both gut-brain axis integrity and neurotransmitter precursor availability; and strict adherence to circadian-aligned sleep hygiene—including consistent bedtime, avoidance of blue light exposure after dusk, and optimization of sleep architecture—facilitates endogenous neurorepair processes.
Recovery from post-stroke emotional dysregulation is neither linear nor immediate. It demands patience, physiological precision, and multidisciplinary coordination—recognizing that mood restoration is inseparable from vascular health, metabolic resilience, and neural reintegration.